openPR Logo
Press release

Gout Disease Treatment Market Will Reflect Significant Growth Prospects till 2020

11-06-2017 06:11 AM CET | Health & Medicine

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Gout Disease Treatment Market Will Reflect Significant Growth

Gout is a disease characterized by recurrent attacks of acute inflammatory arthritis. It occurs when urate crystals accumulate in joint and causes inflammation and intense pain. Urate crystals are formed when high levels of uric acid are present in blood. Human body produces uric acid when it breaks down into purines. Purines are those substances which are present naturally in the body in the form of foods.

The global Gout disease treatment market is categorized based on disease condition and by therapeutics. Gout is mainly classified into acute and chronic Gout. The therapeutic segment is further sub-segmented into anti-inflammatory therapies and urate-lowering therapies.

Request for Report TOC @ https://www.persistencemarketresearch.com/toc/3365

In terms of geographic, North America and Europe dominates the global gout disease treatment market due to improved pharmaceutical and biopharmaceutical research infrastructure in these regions. Several pharmaceutical companies are shifting focus towards research to develop more efficient drugs in North America and Europe. The U.S. represents the largest market for Gout disease treatment followed by Canada in North America. In Europe, France and Germany holds major share of Gout disease treatment market. However, Asia is expected to show high growth rates in the next five years in the global Gout disease treatment market due to increasing awareness among people about the disease. Japan, China and India are expected to be the fastest growing Gout disease treatment markets in Asia.

In recent time, increasing prevalence of Gout disease and strong R&D pipelines are some of the major drivers for the global Gout disease treatment market. In addition, increased research on Gout therapeutics and introduction of novel drugs are also supporting in the growth of global Gout disease treatment market. However, stringent regulations and patent expiry of various blockbuster drugs are key restraints for the global Gout disease treatment market. Increasing mergers and collaborations between major companies and rapid product launches are some of the major trends for the global Gout disease treatment market. In addition, many biopharmaceutical companies are also trying to develop biologics for the treatment of Gout disease. This would develop opportunity for the global Gout disease treatment market.

Request for Report Sample @ https://www.persistencemarketresearch.com/samples/3365

Some of the major companies operating in the global Gout disease treatment market are Takeda Pharmaceutical Company, Novartis, Pfizer and Merck.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact Us

Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
Tel: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gout Disease Treatment Market Will Reflect Significant Growth Prospects till 2020 here

News-ID: 802046 • Views:

More Releases from Persistence Market Research

Solar Cells & Modules Market to Achieve US$ 279.3 Bn by 2032, Driven by Global Renewable Energy Transition and Policy Support
Solar Cells & Modules Market to Achieve US$ 279.3 Bn by 2032, Driven by Global R …
Introduction: Solar Energy as the Backbone of the Clean Power Transition The global energy landscape is undergoing a profound transformation as countries accelerate their shift away from fossil fuels toward cleaner and more sustainable energy sources. Among all renewable options, solar energy has emerged as one of the most scalable, cost-effective, and widely adopted solutions. Solar cells and modules form the core of this transition, enabling the conversion of sunlight into
Cross Laminated Timber Market on Track to Reach US$3.8 Bn by 2032 Driven by Sustainable Construction Demand
Cross Laminated Timber Market on Track to Reach US$3.8 Bn by 2032 Driven by Sust …
Introduction: Cross Laminated Timber as a Game Changer in Construction The cross laminated timber market is gaining strong momentum as the global construction industry shifts toward sustainable, low-carbon building materials. Cross laminated timber, commonly known as CLT, is an engineered wood product made by layering lumber boards crosswise and bonding them together to form large, strong structural panels. This unique structure delivers high strength, dimensional stability, and excellent load-bearing capacity while
Xylanase Market US$2.7 billion by 2033 Revenue Growth Driven by Food & Feed Demand and Enzyme Innovation
Xylanase Market US$2.7 billion by 2033 Revenue Growth Driven by Food & Feed Dema …
Introduction to the Xylanase Market Landscape The xylanase market has emerged as a vital segment within the global industrial enzymes industry, supported by rising demand from food processing, animal nutrition, pulp and paper, and bioenergy sectors. Xylanase enzymes play a crucial role in breaking down xylan, a major hemicellulose component of plant cell walls, thereby improving processing efficiency, product quality, and sustainability outcomes. As industries increasingly prioritize cost efficiency, clean-label ingredients,
Fluorinated Bottles Market Size Valued at US$ 2.0 Billion in 2026 and Expected to Reach US$ 3.2 Billion by 2033 - Persistence Market Research
Fluorinated Bottles Market Size Valued at US$ 2.0 Billion in 2026 and Expected t …
The fluorinated bottles market has emerged as a critical segment within the rigid plastic packaging industry, addressing the growing need for safe storage and transportation of aggressive, volatile, and sensitive chemicals. Fluorinated bottles are plastic containers treated through fluorination processes to enhance their barrier properties, chemical resistance, and durability. This treatment significantly reduces permeability and prevents chemical interactions between the container and its contents, making these bottles indispensable for packaging

All 5 Releases


More Releases for Gout

Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions. Download
Chronic Gout Market Massive Growth opportunity Ahead
Introduction Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032. Gout Therapeutics Market Introduction The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/371311/gout-drugs Market
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with